Sun Pharma UK Ltd

Information

Name

Sun Pharma UK Ltd

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

Address

Uxbridge

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Sun Pharma UK Ltd
Sign up free

Contracts awarded to Sun Pharma UK Ltd

The contracts that Sun Pharma UK Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 19 hours ago

Antiretroviral Drugs

Antiretroviral Drugs

£36,804,647
Award

Published 2 weeks ago

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025 Offer reference number: CM/PHR/22/5683 NHS Framework Agreement for Branded Medicines - Proprietary Category Tender: Period of Framework Agreement: 01 May 2025 to 30 April 2029

£1,241,520,444 Bids close: 4 months ago
Award

Published 2 weeks ago

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025 Offer reference number: CM/PHR/22/5683 CM/PHR/22/5683/00 - NHS Framework Agreement for Branded Medicines - Proprietary Category Tender: Period of Framework Agreement: 01 May 2025 to 30 April 2029

£72
Award

Published 3 months ago

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

£9,867,000 Bids close: 5 months ago
Award

Published 3 months ago

NHS National Framework for Transition products commencing 1 February 2025

Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

£6
Award

Published 4 months ago

NHS National Generic Pharmaceuticals Wave 15a

NHS National Generic Pharmaceuticals - Wave 15a. Offer reference number: CM/PHG/23/5697. Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5697/01 – Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months) CM/PHG/23/5697/02 – Hospital Only Products: DNW & DLN: 01/02/2025 to 31/01/2027 (24 months) CM/PHG/23/5697/03 – Hospital Only Products (Housekeeping): DLS & DNE: 01/02/2025 to 31/05/2026 (16 months) DCE & DSW: 01/02/2025 to 30/09/2025 (8 months)

£170

Sun Pharma UK Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Sun Pharma UK Ltd

Antiretroviral Drugs

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

NHS National Framework for Transition products commencing 1 February 2025

NHS National Generic Pharmaceuticals Wave 15a

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win